Circulating PPi—originating from ABCC6-mediated ATP release and the subsequent breakdown by ENPP1—is known to be significantly reduced in PXE patients compared with healthy controls, and is a potent endogenous inhibitor of calcium crystal formation [41]. Here, ABCC6 is linked to pseudoxanthoma elasticum (inherited or acquired).